Biomarkers of Gynecological Cancers
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: 30 September 2025 | Viewed by 901
Special Issue Editor
Special Issue Information
Dear Colleagues,
This Special Issue, "Biomarkers of Gynecological Cancers", aims to provide a comprehensive overview of the current state of knowledge regarding biomarkers for ovarian, uterine, and cervical cancers. It seeks to highlight recent advancements in the discovery, validation, and clinical application of biomarkers in these gynecological malignancies. The scope of this Special Issue encompasses studies on novel biomarkers, their diagnostic as well as prognostic potential, and their role in guiding personalized treatment strategies. It aims to bring together researchers from diverse fields, including oncology, gynecology, molecular biology, and clinical trials, to discuss the latest findings and challenges in the field of gynecological cancer biomarkers. Through this platform, this Special Issue aims to foster collaboration and advance the development of more effective biomarkers for the early detection, prognosis, and management of gynecological cancers.
Dr. Kelechi Njoku
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biomarkers
- gynecological cancer
- cervical cancer
- ovarian cancer
- uterine cancer
- endometrial cancer
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
